Problems and potentials for human viral cancer vaccines.
D001355:Alpharetrovirus; D000818:Animals; D001353:Avian Leukosis / Q000517:prevention & control; D001717:Birds; D002415:Cats; D004195:Disease Models, Animal; D000882:Haplorhini; D006566:Herpesviridae Infections / Q000150:complications; D006801:Humans; D009052:Leukemia Virus, Murine; D007942:Leukemia, Experimental / Q000517:prevention & control; D008380:Marek Disease / Q000517:prevention & control; D051379:Mice; D009369:Neoplasms / Q000209:etiology / Q000517:prevention & control* / Q000662:veterinary; D009374:Neoplasms, Experimental / Q000517:prevention & control; D014765:Viral Vaccines / Q000627:therapeutic use*
D014765:Viral Vaccines